What is this medicine used for?
FDA-approved uses
- Dementia of the Alzheimer’s type — Adults with mild, moderate or severe Alzheimer’s disease. The 5 and 10 mg oral formulations are used across labeled severity ranges; the 23 mg tablet is reserved for moderate-to-severe disease after prior 10 mg treatment. The branded Aricept ODT product is discontinued; generic oral disintegrating products may be available. This is symptomatic treatment, not a cure.film-coated oral tablets; orally disintegrating tablets.
What should I expect?
Response is assessed over time through thinking and everyday function, often with help from a caregiver. The aim can include preserving function rather than an obvious improvement; benefits vary, and the disease can continue to progress.
Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.
How do I take it safely?
Take the prescribed oral form once daily in the evening, with or without food. A caregiver may help prevent missed or duplicate doses. Dissolve an orally disintegrating tablet on the tongue, then drink water.
The 23 mg tablet is for selected people with moderate-to-severe disease already treated with 10 mg daily for at least three months. It must not be split, crushed, or chewed. Dose changes need the prescriber; check with the pharmacist which dissolving products are available.
Review pulse, fainting, appetite, weight, vomiting, and diarrhea, especially after increases. Tell the care team about ulcers or bleeding, asthma or COPD, seizures, urinary obstruction, and planned anesthesia. Low body weight raises tolerability concerns with the higher strength.
Do not use with known hypersensitivity to donepezil hydrochloride or piperidine derivatives.
Anticholinergic medicines can oppose donepezil’s action; some nonprescription allergy or sleep products have these effects. Other cholinergic medicines and cholinesterase inhibitors may add to adverse effects. Succinylcholine-type muscle relaxants used during anesthesia can have a stronger effect. Aspirin and other NSAIDs increase concern about gastrointestinal bleeding. CYP2D6 or CYP3A4 inhibitors can increase exposure, while certain enzyme-inducing medicines can reduce it. Check the entire medication list, including products bought without a prescription.
There are inadequate human pregnancy data and no adequate data on donepezil in human milk or infant effects in the reviewed label. A specialist should weigh these uncertainties if use is being considered. Pediatric safety and effectiveness are not established. Most clinical participants were older adults. People below 55 kg, about 121 pounds, had more nausea, vomiting and weight loss in the 23 mg trial, making body weight and tolerability especially relevant.
Do not double doses after a missed tablet. Follow the product instructions and ask the pharmacist if timing is unclear. If treatment has been missed for a week or longer, contact the prescriber before restarting; the previous dose should not be resumed automatically.
Discuss stopping with the care team because symptom benefit may diminish after treatment is withdrawn. Decisions should reflect goals of care, function and tolerability, not a fixed rule for every stage of dementia.
What side effects should I know about?
- Nausea, vomiting, diarrhea or reduced appetite.
- Sleep difficulty, muscle cramps or tiredness.
- Weight loss, especially with higher strength or low body weight, needs review.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Aricept tablets and orally disintegrating tablets
Which warning signs need help?
- Fainting, a markedly slow pulse or chest pain requires urgent assessment.
- Bloody vomit, vomit resembling coffee grounds, or black stools may indicate gastrointestinal bleeding.
- Seizures or new serious breathing difficulty require urgent care.
- Get emergency help for trouble breathing, collapse, a seizure, or severe or rapidly worsening symptoms. If thoughts of self-harm put you in immediate danger, seek emergency care now.
What else should I know to stay safe?
- Do not use after allergy to donepezil or related piperidine medicines. Review heart-conduction problems, fainting, ulcers or bleeding, asthma or COPD, seizures, urinary obstruction, and planned anesthesia. Monitor appetite, weight, and gastrointestinal effects, especially after increases and in lower-weight people.
- Anticholinergic medicines, including some nonprescription allergy or sleep products, can oppose donepezil. Other medicines with similar actions may add adverse effects; aspirin and anti-inflammatory medicines add bleeding concerns. Some drugs change donepezil levels, and certain anesthesia muscle relaxants can have stronger effects.
- The 23 mg tablet must not be split, crushed, or chewed and has specific prior-treatment requirements. After a week or more without treatment, contact the prescriber before restarting. Review planned stopping with the care team, and discuss any pregnancy or breastfeeding because relevant human information is inadequate.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- A caregiver’s observations can help identify benefit and tolerability. Keep track of ordinary activities, appetite, weight, and fainting rather than relying only on a brief memory impression.
- The 23 mg tablet has special requirements and cannot be split, crushed, or chewed. A higher-strength tablet is not automatically the next step for everyone.
How does it work?
Donepezil slows the breakdown of acetylcholine, a chemical messenger that helps brain cells communicate. This makes more of the messenger available to support functions such as memory and thinking. The aim is to help with symptoms; donepezil has not been shown to stop the underlying disease process.
Explore more in Brain & Science: Acetylcholine Breakdown: Donepezil.
How was this medicine developed?
The FDA approved Aricept tablets in 1996. Later oral forms included dissolving tablets and a higher-strength tablet with different eligibility and handling requirements. Treatment remains directed at symptoms rather than stopping Alzheimer’s disease.
How do I say the name?
Donepezil: doh-NEP-eh-zil. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
- Donepezil 5 and 10 mg oral tablets
- Aricept 23 mg tablet
- Donepezil orally disintegrating tablets
- Donepezil transdermal product
- Donepezil and memantine combination
Donepezil 5 and 10 mg oral tablets
Oral tablet formulations; indications and escalation are described in the article.
Aricept 23 mg tablet
Moderate-to-severe Alzheimer’s dementia after prior 10 mg therapy; do not split, crush or chew.
Donepezil orally disintegrating tablets
Aricept ODT brand is discontinued in the US; generic alternatives may be available.
Donepezil transdermal product
Transdermal treatment has separate instructions and is not covered by this oral article.
Donepezil and memantine combination
A two-ingredient combination requiring its own product instructions; not equivalent to donepezil alone.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Donepezil: Aricept prescribing information (revised December 2021; date shown is DailyMed record update)
- Donepezil: patient medicine information
- Donepezil: original product approval and regulatory history
- Donepezil: Package Insert / Prescribing Information / MOA
- DailyMed - DONEPEZIL HYDROCHLORIDE tablet, film coated
- Donepezil: verified parent compound, PubChem CID 3152
- Aricept ODT: FDA record and discontinued status
- Aricept 23 mg: FDA approval and product record
- Adlarity: distinct donepezil transdermal system label
- Memantine hydrochloride tablet label — NMDA receptor mechanism
- ISMP List of Confused Drug Names
Giving medicine safely to children: family guide (PDF, 3 pages)

